Johnson D
Office of Product Quality Assessment, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
ArticleKetamine
Process-dependent N-nitroso-ketamine formation during ketamine active pharmaceutical ingredient manufacturing: part I impact of process design, solvent selection, and activated carbon.
ArticlePsilocybin
Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.
ArticlePsilocybin